These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 34342162)
1. Levosimendan improves the acute course of takotsubo syndrome: a pooled analysis. Jaguszewski MJ; Gasecka A; Hering D; Filipiak KJ; Szarpak L; Fijałkowski M; Gruchała M ESC Heart Fail; 2021 Oct; 8(5):4360-4363. PubMed ID: 34342162 [No Abstract] [Full Text] [Related]
2. Levosimendan: New hope therapy for takotsubo syndrome. Hering D; Jaguszewski M Cardiol J; 2016; 23(6):616-617. PubMed ID: 27976790 [No Abstract] [Full Text] [Related]
3. Use of levosimendan for cardiogenic shock in a patient with the apical ballooning syndrome. De Santis V; Vitale D; Tritapepe L; Greco C; Pietropaoli P Ann Intern Med; 2008 Sep; 149(5):365-7. PubMed ID: 18765717 [No Abstract] [Full Text] [Related]
4. Levosimendan accelerates recovery in patients with takotsubo cardiomyopathy. Yaman M; Arslan U; Kaya A; Akyol A; Ozturk F; Okudan YE; Bayramoglu A; Bektas O Cardiol J; 2016; 23(6):610-615. PubMed ID: 27910084 [TBL] [Abstract][Full Text] [Related]
7. Sepsis-associated takotsubo cardiomyopathy can be reversed with levosimendan. Karvouniaris M; Papanikolaou J; Makris D; Zakynthinos E Am J Emerg Med; 2012 Jun; 30(5):832.e5-7. PubMed ID: 21530136 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of levosimendan in Takotsubo-related cardiogenic shock. Antonini M; Stazi GV; Cirasa MT; Garotto G; Frustaci A Acta Anaesthesiol Scand; 2010 Jan; 54(1):119-20. PubMed ID: 19961441 [No Abstract] [Full Text] [Related]
9. Safety and feasibility of levosimendan administration in takotsubo cardiomyopathy: a case series. Santoro F; Ieva R; Ferraretti A; Ienco V; Carpagnano G; Lodispoto M; Di Biase L; Di Biase M; Brunetti ND Cardiovasc Ther; 2013 Dec; 31(6):e133-7. PubMed ID: 24119220 [TBL] [Abstract][Full Text] [Related]
10. How levosimendan can improve renal function? Honore PM; Gutierrez LB; Redant S; Kaefer K; Gallerani A; De Bels D Crit Care; 2019 Oct; 23(1):331. PubMed ID: 31665062 [No Abstract] [Full Text] [Related]
11. Reply to: Levosimendan or dobutamine in patients with low cardiac output syndrome: Results from meta-analysis. Putzu A; Belletti A; Clivio S; Cassina T Int J Cardiol; 2021 Aug; 336():86. PubMed ID: 33965469 [No Abstract] [Full Text] [Related]
12. Levosimendan Comes of Age: 20 Years of Clinical Use. Kurdi M; Pollesello P; Booz GW J Cardiovasc Pharmacol; 2020 Jul; 76(1):1-3. PubMed ID: 32433361 [No Abstract] [Full Text] [Related]
13. Levosimendan or dobutamine in patients with low cardiac output syndrome: Results from meta-analysis. Jaguszewski MJ; Gasecka A; Filipiak KJ; Szarpak L Int J Cardiol; 2021 Jun; 333():145. PubMed ID: 33639185 [No Abstract] [Full Text] [Related]
14. [Reverse takotsubo cardiomyopathy-a life-threatening disease. Successful resuscitation of a 31-year-old woman with cardiologic shock after a visit to the dentist]. Bleser T; Weth C; Görge G Med Klin Intensivmed Notfmed; 2013 Nov; 108(8):675-8. PubMed ID: 24042356 [TBL] [Abstract][Full Text] [Related]
16. Should we keep levosimendan in our pharmacies? Yes, undoubtedly! Cholley B; Caruba T Anaesth Crit Care Pain Med; 2019 Jun; 38(3):211-212. PubMed ID: 31076141 [No Abstract] [Full Text] [Related]
17. Levosimendan for the treatment of acute heart failure syndromes. Parissis JT; Filippatos G; Farmakis D; Adamopoulos S; Paraskevaidis I; Kremastinos D Expert Opin Pharmacother; 2005 Dec; 6(15):2741-51. PubMed ID: 16316312 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Levosimendan in an 84-Year-Old Patient with Takotsubo Syndrome Complicated by Acute Heart Failure. Zalewska-Adamiec M; Chlabicz M; Kuźma Ł; Bachorzewska-Gajewska H; Dobrzycki S Am J Case Rep; 2020 Oct; 21():e927081. PubMed ID: 33077703 [TBL] [Abstract][Full Text] [Related]